global view constructed of white lines

Blog

Esketamine approval for MDD
February 19, 2025

FDA-Approved Nasal Spray for Severe Depression Can Lead to Remission

by Guest Author

The Food and Drug Administration recently approved the nasal spray Spravato (esketamine) for the treatment of MDD in those who have not responded to at least two oral antidepressants. Learn more.

Digital health
February 12, 2025

Is Health Tracking Making You Anxious? Here’s What to Do

by Shannel Elhelou

Health trackers can be a valuable tool for increasing awareness and motivation around physical activity, sleep, stress, and overall well-being. However, for some individuals, constantly monitoring health data can lead to increased anxiety rather than reassurance. Learn more.

the neuroscience of love and connection
February 5, 2025

The Neuroscience of Love and Connection

by Zara Jethani

While love and human connection remain some of the most profound and transformative human experiences, neuroscience has helped demystify their inner workings. Learn more.

Glioblastoma care at Pacific Neuroscience Institute
February 3, 2025

When Chemoradiation Can’t Wait—Treating Glioblastoma in the Face of Disaster

by Emmaline Mauritson

A patient must receive essential treatment for a brain tumor, even during an evacuation warning for the raging Pacific Palisades fire in 2025.

Last updated: February 4th, 2025